I just sent this to President Biden and VP Harris,
I
I just sent this to President Biden and VP Harris,
I carbon copied Dr Fauci, Janet Woodcock, members of the FDA and my State and local representatives. I encourage others to do the same. It is way past time to get LL into the hands of our overworked trained medical staff and to set the example for the rest of the world...
"President Biden and Vice President Harris,
I see the progress that you are making in equality in our country and I appreciate it. However, it has come to my attention that minorities (such as myself) are disproportionately ending up in the ICU with severe to critical covid and dying from this terrible disease. It has also been documented that minorities are being underserved with vaccine distribution. And, finally, it has also come to my attention that there is an answer for all of this.
The drug is called Leronlimab and it has been proven safe and effective in curing covid. The FDA has known for over 10 years that this drug has no adverse effects. Dr. Bruce Patterson was the first to realize that Leronlimab would work to treat covid over a year ago. He and Dr. Fauci have spent many years looking for a cure for aids. This drug, Leronlimab, was originally intended for use in HIV patients of which over1,000 have received treatment in trials and the results have been overwhelmingly positive (it is currently waiting for FDA approval). As a matter of fact very few if any of the current HIV patients receiving Leronlimab have had any issues with Covid.
President Biden, I believe you when you say Black Lives Matter. Leronlimab can be administered in the home. No need to travel needed. This drug can help clear out the ICU's. This drug can save Black lives!
I implore you to look into Leronlimab. Other countries elected officials are currently in the process of approving it for their people. It would be a shame if it was sold overseas before it was made available to all Americans no matter what race, ethnicity, sexual orientation or personal gender identification.
Sincerely,
XXXXXX"
Let's get this sh** done
15
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...
Continue Reading
Grappling with Numbers: Truecaller's Q3 2026 Results A glance at Truecaller's latest report tells us they're banking on a strategic recovery.AOver their recent interim report covering January to September 2026, they disclose a modest 1% decrease in net sales reaching SEK 464 million. Now, if you scoop away the currency fluctuations, net sales climb by a soft 3% from Q2....
Continue Reading
An Infusion of Expertise at Latham & Watkins Alright, folks, Latham & Watkins has just made a rather bold move that deserves some attention, whether you're sipping your morning joe or pondering your next investment strategy. Five big guns in the world of energy and infrastructure have entered the room, bringing their high-stakes project development and finance abilities....
Continue Reading
Dollar Signs and Big Plans: ABVC's Private Placement ABVC BioPharma just bagged $3.39 million through a private placement of senior convertible promissory notes. This ain’t your average financing move, folks. We’re talking original issue discount notes at a hefty 17.5%, maturing by June 2027. This deal takes the cake for today's big plays. Why This Matters to...
Continue Reading
Innovation Meets Contamination: ABC™ Technology Unleashed In the gritty halls of industrial manufacturing, equipment uptime can be the thin red line between profit and chaos. Milwaukee Cylinder just kicked it up a notch with their latest concoction: Active Barrier Chamber (ABC™) technology. This gizmo isn't just another shiny trinket; it's a genuine attempt to wrestle...
Continue Reading
Snagging a career after college isn't quite as easy as catching a football, but the folks over at Johns Hopkins University Athletics and Prospect HQ seem to think they have a playbook for it. You might raise an eyebrow hearing this, but Prospect HQ has now roped in student-athletes from over 500 colleges and universities nationwide into its talent pool. That's a hefty...
Continue Reading
Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...
Continue Reading
Rogers Steps Into the HR Spotlight Out of the Houston heat comes fresh personnel news destined to tweak the interest of anyone watching energy giants like Motiva Enterprises. Terry Rogers, who's been weathering the HR trenches in energy for over 20 years, is stepping into some big shoes as the Executive Vice President of Human Resources. Effective November 1, 2026, Rogers...
Continue Reading
A Deep Dive into Smart Ports The old days of maritime operations are long gone. We're now staring at the future of port operations with these so-called 'smart ports.' The smart port market is bracing to skyrocket, with the valuation expected to leap from USD 4.2 billion in 2026 to a whoppin' USD 23.10 billion by 2034. That’s a galloping CAGR of 23.80%! Investors better...
Continue Reading
Breaking the Conventional Campaign Mold Alright, if someone had told me four decades ago that the gateway to stirring up civic responsibility would be adult entertainment, I would've chuckled at them. But here we are, in 2026, with Hot2Vote making waves by plastering voter turnout messages across Pornhub. Talk about flipping the script on traditional canvassing...
Continue Reading
Top 5 Most Recently Viewed Articles
Del Frisco's Grille Unveils an Innovative Brunch Experience Prepare to indulge in a fresh culinary adventure as Del Frisco's Grille, a renowned contemporary American bar and grill, reintroduces its brunch menu. This menu boasts nine new dishes crafted for the weekend crowd, focusing on shareable experiences and inventive beverages. A Diverse Menu for Everyone Launching...
Continue Reading
Class Action Lawsuit Filed Against Novo Nordisk A/S Pomerantz LLP has announced the initiation of a class action lawsuit against Novo Nordisk A/S (NYSE: NVO). This case targets investors who have sustained losses on their investments in the company. If you believe you are affected by this situation, it is crucial to seek legal advice as soon as possible. Understanding the...
Continue Reading
Understanding the Vision Behind 'Manhattan 2' In recent discussions, Buck Sexton, a notable figure with a background in intelligence, has shed light on an upcoming initiative dubbed 'Manhattan 2'. This project aims to rejuvenate America's global standing, particularly through groundbreaking developments in artificial intelligence technologies. According to Sexton, the...
Continue Reading
The Grounds Guys Celebrate 20 Years of Community Support The Grounds Guys, a proud member of the Neighborly family, has embarked on a remarkable journey by launching its 20th Annual WeCARE Week. This week-long initiative is dedicated to volunteerism and supporting local communities, encouraging franchise owners and team members across North America to join together in...
Continue Reading
KULR Technology Group Launches the KULR ONE Space Presentation KULR Technology Group, Inc. (NYSE: KULR), a leader in sustainable energy management, has just launched the groundbreaking KULR ONE Space presentation. This innovative architecture is tailored to meet NASA's safety standards, optimizing performance across a variety of battery shapes and sizes. It's suitable for...
Continue Reading